Cargando…
Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL
Autores principales: | Prieto, C., López-Millán, B., Roca-Ho, H., Stam, R. W., Romero-Moya, D., Rodríguez-Baena, F. J., Sanjuan-Pla, A., Ayllón, V., Ramírez, M., Bardini, M., De Lorenzo, P., Valsecchi, M. G., Stanulla, M., Iglesias, M., Ballerini, P., Carcaboso, Á. M., Mora, J., Locatelli, F., Bertaina, A., Padilla, L., Rodríguez-Manzaneque, Juan Carlos, Bueno, C., Menéndez, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608364/ https://www.ncbi.nlm.nih.gov/pubmed/30218009 http://dx.doi.org/10.1038/s41375-018-0236-4 |
Ejemplares similares
-
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL
por: Prieto, C, et al.
Publicado: (2018) -
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
por: Lopez-Millan, Belen, et al.
Publicado: (2019) -
Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia
por: van der Linden, Marieke H., et al.
Publicado: (2015) -
The “Never-Ending” Mouse Models for MLL-Rearranged Acute Leukemia Are Still Teaching Us
por: Ottersbach, Katrin, et al.
Publicado: (2018) -
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
por: Muñoz-López, Alvaro, et al.
Publicado: (2016)